Bank Of America Corp Moderna, Inc. Transaction History

Bank Of America Corp

$1.06 Trillion
Q1 2024

A detailed history of Bank Of America Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 917,835 shares of MRNA stock, worth $111 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

917,835

Previous 758,099 21.07%

Holding current value

$111 Million

Previous $75.4 Million 29.73%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $13.6 Million - $18.4 Million	159,736 Added 21.07%	917,835 $97.8 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $2 Million - $3.01 Million	-28,826 Reduced 3.66%	758,099 $75.4 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $20.4 Million - $27.7 Million	-172,372 Reduced 17.97%	786,925 $95.6 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $50.7 Million - $73.6 Million	373,563 Added 63.78%	959,297 $147 Million
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $55.9 Million - $99.2 Million	-472,334 Reduced 44.64%	585,734 $105 Million

Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $25.9 Million - $42.6 Million	219,132 Added 26.12%	1,058,068 $125 Million
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $67.3 Million - $101 Million	-574,391 Reduced 40.64%	838,936 $120 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $33.2 Million - $61.6 Million	262,249 Added 22.78%	1,413,327 $243 Million
Q4 2021 Feb 08, 2022	BUY	$225.82 - $368.51 $79.5 Million - $130 Million	352,026 Added 44.06%	1,151,078 $292 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $24.1 Million - $52.6 Million	108,519 Added 15.72%	799,052 $308 Million
Q2 2021 Sep 13, 2021	BUY	$129.91 - $234.98 $89.7 Million - $162 Million	690,533 New	690,533 $162 Million

Others Institutions Holding MRNA

# of Institutions

1,045

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.34M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $47.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Moderna, Inc. Transaction History